Estimated COVID-19 severe cases and deaths averted in the first year of the vaccination campaign in Brazil: a retrospective observational study

BACKGROUND: A nationwide Severe Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) vaccination campaign was initiated in Brazil in January 2021 with CoronaVac (Sinovac Biotech) and ChAdOx1 nCoV-19 (AstraZeneca) followed by BNT162b2 mRNA (Pfizer–BioNTech) and Ad26.COV2.S (Johnson & Johnson–Janssen)...

Descripción completa

Detalles Bibliográficos
Autores principales: Santos, Cleber Vinicius Brito dos, Noronha, Tatiana Guimarães de, Werneck, Guilherme Loureiro, Struchiner, Claudio José, Villela, Daniel Antunes Maciel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779315/
https://www.ncbi.nlm.nih.gov/pubmed/36575682
http://dx.doi.org/10.1016/j.lana.2022.100418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779315/
https://www.ncbi.nlm.nih.gov/pubmed/36575682
http://dx.doi.org/10.1016/j.lana.2022.100418

Ejemplares similares